サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1726373

甲状腺がん診断の世界市場：市場規模・シェア・動向分析 (がんの種類別・技術別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

Thyroid Cancer Diagnostics Market Size, Share & Trends Analysis Report By Cancer Type (Papillary Carcinoma, Follicular Carcinoma), By Technique (Imaging, Biopsy, Blood Test), By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
甲状腺がん診断の世界市場：市場規模・シェア・動向分析 (がんの種類別・技術別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)
出版日: 2025年04月24日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

甲状腺がん診断市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の甲状腺がん診断市場は2030年までに41億3,000万米ドルに達すると予測され、予測期間のCAGRは5.3％で拡大すると予測されています。

同市場の成長は、疾患有病率の増加と新規診断製品の出現に起因しています。がんは世界的にまれな疾患ですが、罹患率は増加傾向にあり、この疾患を診断するツールの感度と精度が向上していることがその要因となっています。甲状腺がんは、甲状腺における異常な細胞分裂の結果として開発されます。甲状腺ホルモンは、体重、体温、心拍数、血圧などいくつかの機能を調節しているため、構造的または機能的な異常は、前述の因子のいくつかまたはすべてに影響を及ぼす可能性が高いです。

意識の高まりと公衆衛生のイニシアチブは、より多くの個人、特にリスクの高い人々が検診を受けるよう促しています。このことは、医療インフラの拡大や世界の医療費の増加と相まって、高度な診断サービスへのアクセスを促進します。規制当局の支援と継続的な研究努力により、リキッドバイオプシーや人工知能を活用した画像解析など、革新的な診断ソリューションの導入が促進されています。

市場はここ数年、バイオマーカーの導入や改良型診断薬の発売によってパラダイムシフトを遂げています。しかし、疾患の進行と再発は、特に高齢患者において依然として高い水準にあります。強力なアンメットニーズは、画期的なファーストインクラスの診断薬を開発する重要な機会となっています。

甲状腺がん診断市場レポート・ハイライト

  • 乳頭がんは、2024年の売上高シェア80.0%で、がん種セグメントをリードしました。これは、一般市民の意識の高まり、検診イニシアチブの拡大、画像診断および分子診断法の大幅な進歩によるもので、これらすべてが、より早期に、より高い精度で症例を特定することを可能にしました。
  • 濾胞がん診断は、女性の脆弱性の増加、迅速診断の重視、診断技術の継続的な進歩により、予測期間中CAGR 5.6％で成長すると予想されます。
  • 画像診断技術は、2024年に36.9％の最大の売上シェアを占め、腫瘍の正確な位置特定とモニタリングのための画像解像度の向上と人工知能の組み込みが牽引しています。
  • 生検技術は、バイオマーカー解析と次世代シーケンシングの進歩により、診断精度が向上し、個別化治療が可能になったため、予測期間中に大きなCAGRで成長する見込みです。
  • 2024年には、病院検査室が最大の売上シェアを占めています。研究機関は2025年から2030年にかけてCAGR 6.4％で成長する見込みです。
  • 北米は2024年に世界の甲状腺がん診断市場で最大の売上シェアを占め、その主な要因は、高度な医療インフラの存在、継続的な啓発キャンペーン、革新的な診断ソリューションへのアクセスです。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 甲状腺がん診断市場：変動要因・傾向・範囲

  • 市場連関の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
  • 甲状腺がん診断市場：分析ツール
    • 業界分析：ポーターのファイブフォース分析
    • PESTEL分析

第4章 世界の甲状腺がん診断市場：がんの種類別のビジネス分析

  • がんの種類別のダッシュボード
  • 甲状腺がん診断市場：がんの種類別の変動分析
  • 世界の甲状腺がん診断の市場規模と動向分析（がんの種類別、2018～2030年）
  • 乳頭がん
  • 濾胞がん
  • その他

第5章 世界の甲状腺がん診断市場：技術別のビジネス分析

  • 技術別のダッシュボード
  • 甲状腺がん診断市場：技術別の変動分析
  • 世界の甲状腺がん診断の市場規模と動向分析（技術別、2018～2030年）
  • 血液検査
  • 画像診断
  • 生検
  • その他

第6章 世界の甲状腺がん診断市場：最終用途別のビジネス分析

  • 最終用途別のダッシュボード
  • 甲状腺がん診断市場：最終用途別の変動分析
  • 世界の甲状腺がん診断の市場規模と動向分析（最終用途別、2018～2030年）
  • 病院の検査室
  • がん診断センター
  • 研究機関
  • その他

第7章 世界の甲状腺がん診断市場：地域別の推定・動向分析

  • 市場ダッシュボード：地域別
  • 市場シェア分析：地域別（2024年・2030年）
  • 甲状腺がん診断市場：主なポイント、地域別
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 最近の動向と影響分析：主要市場参入企業別
  • 企業/競合の分類
  • ベンダー情勢
    • 主要企業のヒートマップ分析（2024年）
  • 企業プロファイル
    • Abbott
    • F.Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific, Inc.
    • Siemens Healthcare GmbH
    • Bio-Rad Laboratories, Inc.
    • GE HealthCare
    • Hologic, Inc.
    • Koninklijke Philips NV
    • Toshiba Corporation
    • Agilent Technologies, Inc.
    • Illumina, Inc.
図表

List of Tables

  • Table 1 List Of Abbreviations
  • Table 2 Global Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 3 Global Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 4 Global Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 5 Global Thyroid Cancer Diagnostics Market, By Region, 2018-2030, (USD Million)
  • Table 6 North America Thyroid Cancer Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 7 North America Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 8 North America Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 9 North America Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 12 U.S. Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 13 Canada Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 15 Canada Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 16 Mexico Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 17 Mexico Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 18 Mexico Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 19 Europe Thyroid Cancer Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 20 Europe Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 21 Europe Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 22 Europe Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 23 Germany Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 24 Germany Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 25 Germany Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26 UK Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 27 UK Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 28 UK Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 29 France Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 30 France Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 31 France Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32 Italy Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 33 Italy Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 34 Italy Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 35 Spain Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 36 Spain Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 37 Spain Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 38 Denmark Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 39 Denmark Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 40 Denmark Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41 Sweden Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 42 Sweden Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 43 Sweden Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 44 Norway Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 45 Norway Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 46 Norway Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Thyroid Cancer Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 51 China Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 52 China Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 53 China Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 54 Japan Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 55 Japan Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 56 Japan Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 57 India Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 58 India Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 59 India Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 60 South Korea Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 61 South Korea Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 62 South Korea Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 63 Australia Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 64 Australia Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 65 Australia Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 66 Thailand Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 67 Thailand Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 68 Thailand Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 69 Latin America Thyroid Cancer Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 71 Latin America Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 72 Latin America Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 73 Brazil Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 74 Brazil Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 75 Argentina Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 76 Argentina Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 77 Argentina Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 78 MEA Thyroid Cancer Diagnostics Market, By Region, 2018 - 2030 (USD Million)
  • Table 79 MEA Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 80 MEA Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 81 MEA Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 82 South Africa Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 83 South Africa Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 84 South Africa Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 88 UAE Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 89 UAE Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 90 UAE Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 91 Kuwait Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Thyroid Cancer Diagnostics Market: Market Outlook
  • Fig. 10 Thyroid Cancer Diagnostics Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Thyroid Cancer Diagnostics Market Driver Impact
  • Fig. 16 Thyroid Cancer Diagnostics Market Restraint Impact
  • Fig. 17 Thyroid Cancer Diagnostics Market Strategic Initiatives Analysis
  • Fig. 18 Thyroid Cancer Diagnostics Market: Cancer Type Movement Analysis
  • Fig. 19 Thyroid Cancer Diagnostics Market: Cancer Type Outlook and Key Takeaways
  • Fig. 20 Papillary Carcinoma Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 Follicular Carcinoma Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 Others Market Estimates and Forecast, 2018 - 2030
  • Fig. 23 Thyroid Cancer Diagnostics Market: Technique Movement Analysis
  • Fig. 24 Thyroid Cancer Diagnostics Market: Technique Outlook and Key Takeaways
  • Fig. 25 Blood Test Market Estimates and Forecast, 2018 - 2030
  • Fig. 26 Imaging Market Estimates and Forecast, 2018 - 2030
  • Fig. 27 Biopsy Market Estimates and Forecast, 2018 - 2030
  • Fig. 28 Others Market Estimates and Forecast, 2018 - 2030
  • Fig. 29 Thyroid Cancer Diagnostics Market: End Use Movement Analysis
  • Fig. 30 Thyroid Cancer Diagnostics Market: End Use Outlook and Key Takeaways
  • Fig. 31 Hospital Laboratories Market Estimates and Forecasts, 2018 - 2030
  • Fig. 32 Cancer Diagnostic Centers Market Estimates and Forecasts, 2018 - 2030
  • Fig. 33 Research Institutes Market Estimates and Forecasts, 2018 - 2030
  • Fig. 34 Others Market Estimates and Forecasts, 2018 - 2030
  • Fig. 35 Global Thyroid Cancer Diagnostics Market: Regional Movement Analysis
  • Fig. 36 Global Thyroid Cancer Diagnostics Market: Regional Outlook and Key Takeaways
  • Fig. 37 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 38 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 39 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 41 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 42 UK Market Estimates and Forecasts, 2018 - 2030
  • Fig. 43 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 45 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 47 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 49 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 51 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 53 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 59 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 60 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 61 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 62 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 63 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 64 Kuwait Market Estimates and Forecasts, 2018 - 2030
目次
Product Code: GVR-4-68038-615-8

Thyroid Cancer Diagnostics Market Growth & Trends:

The global thyroid cancer diagnostics market is anticipated to reach USD 4.13 billion by 2030 and is anticipated to expand at a CAGR of 5.3% over the forecast period, according to a new report by Grand View Research, Inc. The growth of the market is attributed to increasing disease prevalence and the emergence of novel diagnostic products. Although cancer is uncommon worldwide, the incidence rate is on the rise-driven by more sensitive and precise tools to diagnose the disease. It develops as a result of abnormal cell division in the thyroid gland. Since the glandular hormones regulate several functions, such as weight, body temperature, heart rate, and blood pressure, structural or functional anomalies are likely to affect several or all of the aforementioned factors.

Growing awareness and public health initiatives encourage more individuals, especially those at higher risk, to seek screening. This, combined with expanding healthcare infrastructure and increased healthcare spending worldwide, facilitates greater access to advanced diagnostic services. Regulatory support and ongoing research efforts are fostering the introduction of innovative diagnostic solutions, including liquid biopsies and artificial intelligence-driven imaging analysis.

The market has undergone a paradigm shift over the last few years, driven by the introduction of biomarkers and the launch of improved diagnostic products. However, disease progression and recurrence remain high, especially among older patients. Strong unmet needs present a key opportunity to develop breakthrough, first-in-class diagnostics of the disease.

Thyroid Cancer Diagnostics Market Report Highlights:

  • Papillary carcinoma led the cancer type segment with the largest revenue share of 80.0% in 2024. This is attributed to heightened public awareness, the expansion of screening initiatives, and significant progress in imaging and molecular diagnostic methods, all of which have made it possible to identify cases earlier and with greater accuracy.
  • Follicular carcinoma diagnostics is expected to grow at a CAGR of 5.6% over the forecast period, owing to an increased vulnerability among women, a stronger emphasis on prompt diagnosis, and ongoing advancements in diagnostic technologies.
  • Imaging technique held the largest revenue share, 36.9%, in 2024, driven by the incorporation of enhanced imaging resolution and artificial intelligence for precise tumor localization and monitoring.
  • Biopsy technique is expected to grow at a significant CAGR over the forecast period, owing to advances in biomarker analysis and next-generation sequencing, which have improved diagnostic accuracy and supported individualized care.
  • Hospital laboratories accounted for the largest revenue share in 2024. Research institutes are expected to grow at a CAGR of 6.4% from 2025 to 2030.
  • North America dominated the global thyroid cancer diagnostics market with the largest revenue share in 2024, primarily driven by the presence of advanced healthcare infrastructure, ongoing awareness campaigns, and access to innovative diagnostic solutions.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Cancer Type
    • 1.2.2. Technique
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Cancer Type Outlook
    • 2.2.2. Technique Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Thyroid Cancer Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Global Thyroid Cancer Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Global Thyroid Cancer Diagnostics Market: Cancer Type Business Analysis

  • 4.1. Cancer Type Segment Dashboard
  • 4.2. Thyroid Cancer Diagnostics Market: Cancer Type Movement Analysis
  • 4.3. Global Thyroid Cancer Diagnostics Market Size & Trend Analysis, By Cancer Type, 2018 to 2030 (USD Million)
  • 4.4. Papillary carcinoma
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Follicular carcinoma
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Thyroid Cancer Diagnostics Market: Technique Business Analysis

  • 5.1. Technique Segment Dashboard
  • 5.2. Thyroid Cancer Diagnostics Market: Technique Movement Analysis
  • 5.3. Global Thyroid Cancer Diagnostics Market Size & Trend Analysis, By Technique, 2018 to 2030 (USD Million)
  • 5.4. Blood Test
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Imaging
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Biopsy
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Thyroid Cancer Diagnostics Market: End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Thyroid Cancer Diagnostics Market: End Use Movement Analysis
  • 6.3. Global Thyroid Cancer Diagnostics Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospital Laboratories
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Cancer Diagnostic Centers
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. Research Institutes
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Global Thyroid Cancer Diagnostics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Global Thyroid Cancer Diagnostics Market by Regional: Key Takeaways
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key Country Dynamics
      • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.1.3. Competitive Scenario
      • 7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Germany
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.1.3. Competitive Scenario
      • 7.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Denmark
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.8.3. Competitive Scenario
      • 7.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.1.3. Competitive Scenario
      • 7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Thailand
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. South Africa
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key Company Heat Map Analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Abbott
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. F.Hoffmann-La Roche Ltd.
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Thermo Fisher Scientific, Inc.
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Siemens Healthcare GmbH
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Bio-Rad Laboratories, Inc.
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. GE HealthCare
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Hologic, Inc.
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Koninklijke Philips N.V.
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Toshiba Corporation
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Agilent Technologies, Inc.
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. Illumina, Inc.
      • 8.4.11.1. Company Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Strategic Initiatives